Keywords: novomix, leads, hba1c, drop, insulin-naive, patients, new

NovoMix 30 leads to 2.4% HbA1c drop in insulin-naive patients.

Article | 15 September 2008

Print This

New data from IMPROVE - the largest ever observational study in diabetes - show that treatment with Novo Nordisk's premixed ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in